Physiogenex is delighted to be awarded ISO 9001:2015, a globally recognized certification of quality management system standards.
Our scope of certification « Preclinical research in pharmacology » includes in vivo and ex vivo CRO services delivered by Physiogenex. Our quality management system ensures that our products and services meet the needs of our clients, legal and internal requirements.
We have had an internal quality assurance program and internal audit system in place for over 10 years to guarantee the high quality of our services. By achieving this level of certification, Physiogenex continues to demonstrate our principles including a strong customer focus, the motivation, and the implication of our teams.
Gaining ISO 9001:2015 reinforces Physiogenex relentless focus in making continual efforts to provide our clients with the best deliverables, on time and of the highest quality.
Feel free to contact us if you wish to set-up an appointment with our team to discuss your drug development projects with us.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis), cardiovascular and renal complications.